| abstract |
REFERRED TO A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN INSULIN COMPOUND IN A CONCENTRATION OF BETWEEN 10 MG / ML AND 35 MG / ML AND IS SELECTED FROM HUMAN INSULIN, INSULIN GLARGIN, INSULIN DETEMIR, INSULIN LISPRO, INSULIN ASPART, INSULIN GLUSIN. IT ALSO INCLUDES A GLP-1 COMPOUND AND IN ADDITION, IT MAY INCLUDE ONE OR MORE ACTIVE AGENTS SUCH AS SULFONYLUREAS, DIPEPTIL PROTEASE INHIBITORS, BIGUANIDES, AMONG OTHERS |